Skip to content

OS Therapies OSTX Gross Proceeds

Gross Proceeds at other companies

Spectral AI, Inc. logo
Spectral AI, Inc.MDAI
$7.6M+300%
Alpha Cognition logo
Alpha CognitionACOG
$5.25M
Spectral AI, Inc. logo
Spectral AI, Inc.MDAI
$7.6M+300%
XTI Aerospace, Inc. logo
XTI Aerospace, Inc.XTIA
$22.8M
KEE
Keel Infrastructure Corp. Common StockKEEL
$142.27M
Bit Digital logo
Bit DigitalBTBT
$147.4M

Other financials

Income statement

See full
Operating income-$10.2M-103%
Net income-$10.4M-168%
EPS (diluted)-$0.27-50.0%

Balance sheet

See full
Cash & equivalents$917.6K-69.1%
Total debt$20.0M
Total equity-$10.8M-159%
Total assets$7.3M+71.7%

Cash flow

See full
Operating cash flow-$4.6M-32.6%
CapEx$316.4K
Free cash flow-$3.7M

Valuation

See full
Market cap$84.62M+66.4%
Enterprise value$103.7M

Returns & leverage

See full
Return on equity470%
Debt / equity-1.8×
Current ratio0.1×-1.1×

Where this comes from

Reported directly by OS Therapies in its filing.

Tagged under the XBRL concept osti:GrossProceeds.

The official record: OS Therapies’s 10-K, filed March 31, 2026, on SEC EDGAR. View the filing →

Ask your AI about OS Therapies's gross proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OS Therapies's gross proceeds?
OS Therapies (OSTX) reported gross proceeds of $625K in Q4 2025.
What does gross proceeds mean?
This metric represents the total cash inflows generated from financing activities, such as equity offerings, warrant exercises, or other capital-raising events, before the deduction of any associated issuance costs or fees. It serves as a primary indicator of the company's ability to access capital markets to fund ongoing research, development, and operational requirements. Tracking this value provides insight into the company's liquidity position and its success in securing external funding to sustain its clinical-stage pipeline.